AH

Andy Hill Cancer Research Endowment (CARE) Fund

North America, Washington, United States, Bothell

Description

Andy Hill CARE Fund is a fund that invests in public and private entities to promote research in the prevention and treatment of cancer.

Investor Profile

Andy Hill Cancer Research Endowment (CARE) Fund has made 4 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Grant (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Clinical Trials
  • Therapeutics
  • 3d Technology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Andy Hill Cancer Research Endowment (CARE) Fund frequently co-invest with?

National Institutes of Health
North America, Maryland, United States, Bethesda
Co-Investments: 1
NI
North America, Maryland, United States, Bethesda
Co-Investments: 1

What are some of recent deals done by Andy Hill Cancer Research Endowment (CARE) Fund?

Deverra Therapeutics

Seattle, Washington, United States

Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.

BiotechnologyClinical TrialsMedical
GrantSep 11, 2023
Amount Raised: $3,500,000
Talus Bio

Seattle, Washington, United States

Talus Bio is a drug discovery biotech startup working on drug development for gene regulators.

BiotechnologyHealth CareTherapeutics
GrantAug 18, 2023
Amount Raised: $4,300,000
Alpenglow Biosciences

Seattle, Washington, United States

Alpenglow Biosciences is an end-to-end 3D pathology platform that aims to accelerate drug development and improve clinical diagnostics.

3D TechnologyLife ScienceMedical
GrantAug 1, 2023
Amount Raised: $1,600,000
KayoThera

Princeton, New Jersey, United States

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

BiotechnologyHealth CareMedical
GrantJul 19, 2023